title: Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia.
abstract: Allogeneic blood or bone marrow transplantation is a successful treatment for leukaemia and severe aplastic anaemia (SAA). Graft rejection following transplantation for leukaemia is a rare event but leukaemic relapse may occur at varying rates, depending upon the stage of leukaemia at which the transplant was undertaken and the type of leukaemia. Relapse is generally assumed to occur in residual host cells, which are refractory to, or escape from the myeloablative conditioning therapy. Rare cases have been described, however, in which the leukaemia recurs in cells of donor origin. Lack of a successful outcome of blood or bone marrow transplantation for severe aplastic anaemia (SAA), however, is due to late graft rejection or graft-versus-host disease. Leukaemia in cells of donor origin has rarely been reported in patients following allogeneic bone marrow transplantation for SAA. This report describes leukaemic transformation in donor cells following a second allogeneic BMT for severe aplastic anaemia. PCR of short tandem repeats in bone marrow aspirates and in colonies derived from BFUE and CFU-GM indicated the donor origin of leukaemia. Donor leukaemia is a rare event following transplantation for severe aplastic anaemia but may represent the persistence or perturbation of a stromal defect in these patients inducing leukaemic change in donor haemopoietic stem cells.
authors.affiliation: Department of Haematology, Sir Patrick Dun Research Laboratory, Trinity College Dublin and St James's Hospital, Dublin, Ireland.
authors.forename: M
authors.initials: M
authors.lastname: Lawler
authors.forename: A
authors.initials: A
authors.lastname: Locasciulli
authors.forename: D
authors.initials: D
authors.lastname: Longoni
authors.forename: R
authors.initials: R
authors.lastname: Schiro
authors.forename: S R
authors.initials: SR
authors.lastname: McCann
mesh_terms: D000741:Anemia, Aplastic / Q000150:complications / Q000628:therapy*; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D002471:Cell Transformation, Neoplastic; D002648:Child; D005260:Female; D006801:Humans; D007938:Leukemia / Q000209:etiology* / Q000473:pathology; D016133:Polymerase Chain Reaction; D020080:Tandem Repeat Sequences / Q000235:genetics; D014019:Tissue Donors; D018183:Transplantation Chimera; D014184:Transplantation, Homologous